Asset Management
Build Your Comparison
Side-by-side financial analysisStock Comparison
FHI vs VRTS vs BEN vs VCTR vs IVZ
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Asset Management
FHI vs VRTS vs BEN vs VCTR vs IVZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $4.49B | $948M | $17.17B | $5.57B | $12.50B |
| Revenue (TTM) | $1.86B | $831M | $9.03B | $1.47B | $6.59B |
| Net Income (TTM) | $399M | $138M | $812M | $380M | $-243M |
| Gross Margin | 51.5% | 74.9% | 73.8% | 70.9% | 50.7% |
| Operating Margin | 27.4% | 17.4% | 9.3% | 43.4% | -9.7% |
| Forward P/E | 11.6x | 5.8x | 12.1x | 12.2x | 10.9x |
| Total Debt | $457M | $2.84B | $13.30B | $970M | $10.12B |
| Cash & Equiv. | $584M | $477M | $3.57B | $164M | $1.98B |
FHI vs VRTS vs BEN vs VCTR vs IVZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Federated Hermes, I… (FHI) | 100 | 249.2 | +149.2% |
| Virtus Investment P… (VRTS) | 100 | 121.8 | +21.8% |
| Franklin Resources,… (BEN) | 100 | 157.6 | +57.6% |
| Victory Capital Hol… (VCTR) | 100 | 506.2 | +406.2% |
| Invesco Ltd. (IVZ) | 100 | 261.5 | +161.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FHI vs VRTS vs BEN vs VCTR vs IVZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FHI ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 11.0%, EPS growth 58.8%
- Lower volatility, beta 0.70, Low D/E 36.2%, current ratio 41.26x
- Beta 0.70 vs IVZ's 1.61, lower leverage
VRTS is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 8 yrs, beta 1.06, yield 6.6%
- PEG 0.39 vs VCTR's 1.69
- Beta 1.06, yield 6.6%, current ratio 3.80x
- NIM 0.9% vs FHI's 0.5%
Among these 5 stocks, BEN doesn't own a clear edge in any measured category.
VCTR carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 7.2% 10Y total return vs FHI's 144.4%
- 46.2% NII/revenue growth vs VRTS's -8.0%
- Efficiency ratio 0.3% vs BEN's 0.7% (lower = leaner)
- Efficiency ratio 0.3% vs BEN's 0.7%
IVZ is the clearest fit if your priority is momentum.
- +96.9% vs VRTS's -13.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.2% NII/revenue growth vs VRTS's -8.0% | |
| Value | Lower P/E (5.8x vs 12.2x), PEG 0.39 vs 1.69 | |
| Quality / Margins | Efficiency ratio 0.3% vs BEN's 0.7% (lower = leaner) | |
| Stability / Safety | Beta 0.70 vs IVZ's 1.61, lower leverage | |
| Dividends | 6.6% yield, 8-year raise streak, vs VCTR's 2.2% | |
| Momentum (1Y) | +96.9% vs VRTS's -13.2% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs BEN's 0.7% |
FHI vs VRTS vs BEN vs VCTR vs IVZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FHI vs VRTS vs BEN vs VCTR vs IVZ — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VCTR leads in 2 of 6 categories
VRTS leads 2 • FHI leads 2 • BEN leads 0 • IVZ leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
VCTR leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BEN is the larger business by revenue, generating $9.0B annually — 10.9x VRTS's $831M. VCTR is the more profitable business, keeping 25.8% of every revenue dollar as net income compared to IVZ's -3.7%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.9B | $831M | $9.0B | $1.5B | $6.6B |
| EBITDAEarnings before interest/tax | $527M | $205M | $1.2B | $726M | $1.2B |
| Net IncomeAfter-tax profit | $399M | $138M | $812M | $380M | -$243M |
| Free Cash FlowCash after capex | $307M | -$67M | $938M | $422M | $1.9B |
| Gross MarginGross profit ÷ Revenue | +51.5% | +74.9% | +73.8% | +70.9% | +50.7% |
| Operating MarginEBIT ÷ Revenue | +27.4% | +17.4% | +9.3% | +43.4% | -9.7% |
| Net MarginNet income ÷ Revenue | +21.4% | +16.7% | +9.0% | +25.8% | -3.7% |
| FCF MarginFCF ÷ Revenue | +16.5% | -8.1% | +10.4% | +28.6% | +28.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +1.6% | +10.9% | +100.0% | +38.5% | +34.2% |
Valuation Metrics
VRTS leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 7.1x trailing earnings, VRTS trades at a 80% valuation discount to BEN's 36.3x P/E. Adjusting for growth (PEG ratio), VRTS offers better value at 0.48x vs VCTR's 2.96x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.5B | $948M | $17.2B | $5.6B | $12.5B |
| Enterprise ValueMkt cap + debt − cash | $4.4B | $3.3B | $26.9B | $6.4B | $20.6B |
| Trailing P/EPrice ÷ TTM EPS | 11.51x | 7.09x | 36.32x | 21.33x | -17.58x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.56x | 5.81x | 12.06x | 12.17x | 10.91x |
| PEG RatioP/E ÷ EPS growth rate | 1.19x | 0.48x | — | 2.96x | — |
| EV / EBITDAEnterprise value multiple | 7.82x | 16.19x | 23.68x | 10.16x | 16.82x |
| Price / SalesMarket cap ÷ Revenue | 2.48x | 1.14x | 1.96x | 4.27x | 1.96x |
| Price / BookPrice ÷ Book value/share | 3.51x | 0.95x | 1.20x | 2.38x | 0.98x |
| Price / FCFMarket cap ÷ FCF | 15.23x | — | 18.84x | 23.53x | 8.68x |
Profitability & Efficiency
FHI leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
FHI delivers a 29.5% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $-2 for IVZ. FHI carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRTS's 2.74x. On the Piotroski fundamental quality scale (0–9), FHI scores 8/9 vs VCTR's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +29.5% | +13.5% | +5.6% | +15.8% | -1.7% |
| ROA (TTM)Return on assets | +18.2% | +3.6% | +2.5% | +9.0% | -0.9% |
| ROICReturn on invested capital | +24.1% | +3.0% | +1.6% | +15.2% | -2.3% |
| ROCEReturn on capital employed | +26.3% | +3.7% | +2.0% | +17.8% | -2.6% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 6 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.36x | 2.74x | 0.94x | 0.40x | 0.78x |
| Net DebtTotal debt minus cash | -$127M | $2.4B | $9.7B | $806M | $8.1B |
| Cash & Equiv.Liquid assets | $584M | $477M | $3.6B | $164M | $2.0B |
| Total DebtShort + long-term debt | $457M | $2.8B | $13.3B | $970M | $10.1B |
| Interest CoverageEBIT ÷ Interest expense | 44.07x | 2.15x | 15.19x | 8.35x | -6.19x |
Total Returns (Dividends Reinvested)
VCTR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VCTR five years ago would be worth $31,230 today (with dividends reinvested), compared to $6,784 for VRTS. Over the past 12 months, IVZ leads with a +96.9% total return vs VRTS's -13.2%. The 3-year compound annual growth rate (CAGR) favors VCTR at 42.0% vs VRTS's -7.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.2% | -9.9% | +40.3% | +37.3% | +6.0% |
| 1-Year ReturnPast 12 months | +43.1% | -13.2% | +52.1% | +42.0% | +96.9% |
| 3-Year ReturnCumulative with dividends | +69.2% | -19.9% | +40.7% | +186.2% | +85.1% |
| 5-Year ReturnCumulative with dividends | +101.8% | -32.2% | +25.5% | +212.3% | +22.2% |
| 10-Year ReturnCumulative with dividends | +144.4% | +144.2% | +39.9% | +715.8% | +30.3% |
| CAGR (3Y)Annualised 3-year return | +19.2% | -7.1% | +12.1% | +42.0% | +22.8% |
Risk & Volatility
FHI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
FHI is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than IVZ's 1.61 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FHI currently trades 98.7% from its 52-week high vs VRTS's 65.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.70x | 1.07x | 1.26x | 1.15x | 1.61x |
| 52-Week HighHighest price in past year | $59.83 | $215.06 | $34.17 | $90.19 | $29.82 |
| 52-Week LowLowest price in past year | $41.71 | $121.61 | $21.11 | $57.03 | $14.48 |
| % of 52W HighCurrent price vs 52-week peak | +98.7% | +65.8% | +96.7% | +96.5% | +94.4% |
| RSI (14)Momentum oscillator 0–100 | 67.2 | 49.8 | 66.7 | 56.0 | 59.2 |
| Avg Volume (50D)Average daily shares traded | 734K | 97K | 4.2M | 470K | 4.3M |
Analyst Outlook
VRTS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FHI as "Hold", VRTS as "Hold", BEN as "Hold", VCTR as "Buy", IVZ as "Hold". Consensus price targets imply 6.8% upside for IVZ (target: $30) vs -4.2% for VRTS (target: $136). For income investors, VRTS offers the higher dividend yield at 6.58% vs VCTR's 2.17%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $57.50 | $135.67 | $32.00 | $86.50 | $30.06 |
| # AnalystsCovering analysts | 21 | 11 | 27 | 13 | 28 |
| Dividend YieldAnnual dividend ÷ price | +2.4% | +6.6% | +4.0% | +2.2% | +3.0% |
| Dividend StreakConsecutive years of raises | 3 | 8 | 2 | 7 | 4 |
| Dividend / ShareAnnual DPS | $1.40 | $9.32 | $1.33 | $1.89 | $0.83 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.9% | +6.3% | +1.4% | +2.6% | +14.9% |
VCTR leads in 2 of 6 categories (Income & Cash Flow, Total Returns). VRTS leads in 2 (Valuation Metrics, Analyst Outlook).
FHI vs VRTS vs BEN vs VCTR vs IVZ: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FHI or VRTS or BEN or VCTR or IVZ a better buy right now?
For growth investors, Victory Capital Holdings, Inc.
(VCTR) is the stronger pick with 46. 2% revenue growth year-over-year, versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). Virtus Investment Partners, Inc. (VRTS) offers the better valuation at 7. 1x trailing P/E (5. 8x forward), making it the more compelling value choice. Analysts rate Victory Capital Holdings, Inc. (VCTR) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FHI or VRTS or BEN or VCTR or IVZ?
On trailing P/E, Virtus Investment Partners, Inc.
(VRTS) is the cheapest at 7. 1x versus Franklin Resources, Inc. at 36. 3x. On forward P/E, Virtus Investment Partners, Inc. is actually cheaper at 5. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Virtus Investment Partners, Inc. wins at 0. 39x versus Victory Capital Holdings, Inc. 's 1. 69x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FHI or VRTS or BEN or VCTR or IVZ?
Over the past 5 years, Victory Capital Holdings, Inc.
(VCTR) delivered a total return of +212. 3%, compared to -32. 2% for Virtus Investment Partners, Inc. (VRTS). Over 10 years, the gap is even starker: VCTR returned +715. 8% versus IVZ's +30. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FHI or VRTS or BEN or VCTR or IVZ?
By beta (market sensitivity over 5 years), Federated Hermes, Inc.
(FHI) is the lower-risk stock at 0. 70β versus Invesco Ltd. 's 1. 61β — meaning IVZ is approximately 131% more volatile than FHI relative to the S&P 500. On balance sheet safety, Federated Hermes, Inc. (FHI) carries a lower debt/equity ratio of 36% versus 3% for Virtus Investment Partners, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FHI or VRTS or BEN or VCTR or IVZ?
By revenue growth (latest reported year), Victory Capital Holdings, Inc.
(VCTR) is pulling ahead at 46. 2% versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). On earnings-per-share growth, the picture is similar: Federated Hermes, Inc. grew EPS 58. 8% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FHI or VRTS or BEN or VCTR or IVZ?
Victory Capital Holdings, Inc.
(VCTR) is the more profitable company, earning 25. 3% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 25. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VCTR leads at 42. 5% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — BEN leads at 80. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FHI or VRTS or BEN or VCTR or IVZ more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Virtus Investment Partners, Inc. (VRTS) is the more undervalued stock at a PEG of 0. 39x versus Victory Capital Holdings, Inc. 's 1. 69x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Virtus Investment Partners, Inc. (VRTS) trades at 5. 8x forward P/E versus 12. 2x for Victory Capital Holdings, Inc. — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IVZ: 6. 8% to $30. 06.
08Which pays a better dividend — FHI or VRTS or BEN or VCTR or IVZ?
All stocks in this comparison pay dividends.
Virtus Investment Partners, Inc. (VRTS) offers the highest yield at 6. 6%, versus 2. 2% for Victory Capital Holdings, Inc. (VCTR).
09Is FHI or VRTS or BEN or VCTR or IVZ better for a retirement portfolio?
For long-horizon retirement investors, Federated Hermes, Inc.
(FHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 4% yield, +144. 4% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FHI: +144. 4%, IVZ: +30. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FHI and VRTS and BEN and VCTR and IVZ?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FHI is a small-cap deep-value stock; VRTS is a small-cap deep-value stock; BEN is a mid-cap income-oriented stock; VCTR is a small-cap high-growth stock; IVZ is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.